Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117225) titled 'A study to assess the effectiveness and safety of topical tofacitinib cream in adults with melasma' on Sept. 8.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Dr D Y Patil Medical College Hospital and Research Centre
Condition:
Health Condition 1: L811- Chloasma
Intervention:
Intervention1: Topical tofacitinib 2 percent cream: Topical tofacitinib 2 percent cream applied twice daily in the morning and night to all affected melasma lesi...